STAT

TB vaccines can vary greatly, study finds. But does that mean some are less protective?

A new study catalogued how many live, but weakened, bacteria are in TB vaccines from different manufacturers — and some turn out to have 10- to 1,000-fold more than others.
A child receives a TB vaccine at Brewelskloof Hospital in Worcester, South Africa.

It all started with a bit of bacteria swiped from the udder of a tuberculous French cow. Initially, it was just another livestock sample, a speck of virulence lounging in a Paris lab. But then it began to change. Two scientists had brought some of it to Lille, near the Belgian border, and had fed it a concoction of potato, glycerin, and ox bile. The bugs liked this witches’ brew, and multiplied, and multiplied again.

After years away from live animal hosts, the bacterium got used to its cushy lab-dish life and lost its barnyard edge. Enough of its tough old self remained to trigger a body’s immune defenses, but not enough to make a healthy person sick. Perfect for a microbial training drill. Word spread. Scientists made pilgrimages to France, to take home some defused.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks